The possible influence of the concomitant administration of cefotiam and cefsulodin on their respective pharmacokinetics was studied in 15 patients with renal insufficiency and 10 anuric patients. Linear relations were found between the clearance of creatinine and the total clearance, as wei as the renal clearance, of each drug. These relations for each cephalosporin were not significantly different from previous results obtained after separate administration. In hemodialyzed patients, the two cephalosporins were readily eliminated from the blood after simultaneous administration: ca. 35% of the dose of cefotiam and 30% of the dose of cefsulodin was recovered in the dialysate over 5 h. These results suggest that the pharmacokinetics of the two drugs are not modified by their simultaneous administration and that the dosing schedule previously proposed for administration of the two cephalosporins alone in the presence of renal insufficiency can be applied without modification when they are given together. Patients on hemodialysis should receive a loading dose after each dialysis period, and then reduced doses according to recommendations for anuric patients.
Cefotiam is active against a broad spectrum of bacteria (11) . Cefsulodin displays pronounced activity against Pseudomonas aeruginosa (9, 12) . The concomitant administration of these two cephalosporins appears to be the treatment of choice in cases of severe mixed infection (5) . A synergistic effect of cefsulodin and cefotiam against Serratia marcescens has also been reported (10) . The present investigation was undertaken to determine whether the simultaneous administration of cefotiam and cefsulodin modifies their respective pharmacokinetics in patients with impaired renal function. In anuric patients under hemodialysis, two different cefsulodin-cefotiam dosages were administered to investigate, for therapeutic purposes, whether the ratio of cefsulodin to cefotiam doses may influence the pharmacokinetics of the two drugs. The pharmacokinetics of cefsulodin given alone to patients with renal insufficiency has already been described (3, 4, 7) ; that of cefotiam will be reported (M. C. Rouan, U. Binswanger, F. Bammatter, W. Theobald, J. P. Schoeller, and J. Guibert, Antimicrob. Chemother., in press).
In the present paper, the results of our previous studies with cefotiam (Rouan et al., in press) and cefsulodin (7) given alone to Table 4 .
Dialyzed patients. Both cephalosporins were eliminated in the dialysate (Tables 5 and 6 ), and no significant variations in the amounts eliminated in the dialysate were seen (P = 0.05) after the administration of the different combinations, indi- cating that they can be given together to dialysis patients in doses of 1 of 2 g without risk of accumulation. DISCUSSION Cefotiam and cefsulodin were eliminated mainly by renal processes (7; Rouan et al., in press). Plots of the CLT or CLR of each drug as a function of creatinine clearance (Fig. 1) gave linear relations, after their simultaneous administration, not significantly different (slope and intercept) from those recorded when the two drugs were administered separately. Hence, no competitive effect due to combined administration takes place.
At the stage of severe renal insufficiency, the renal clearance slightly deviates from the linearity and remains above the regression lines for subjects whose CLCR was below 10 ml/min. In these patients, renal excretion becomes the minor route of elimination, and nonrenal processes predominate. This is reflected by the close values of CLT and CLNR in patients 2 to 7, whose CLCRs were 3 to 10 ml/min (Tables 2   and 3 ). The mean results found in this study and those previously found after separate administration are given in Table 7 for these patients with severe renal impairment. They were not significantly different (P = 0.05), and the nonrenal elimination appeared similar whether the drugs were given separately or together.
In dialyzed patients, the two drugs were eliminated in the dialysate. In a previous study (7) , the mean recovery in the dialysate over 6 h was 45 ± 10% of the dose in six patients receiving cefsulodin alone. The elimination was thus slightly higher than after simultaneous administration. This discrepancy can be explained by the difference in the dialysate and blood mean flow rates, which were 580 and 325 ml/min, respectively, after cefsulodin administration in the earlier study (7) . Moreover, in the present study, the elimination of the dialysate was only determined over 5 h.
The volume of distribution Varea was similar for the two drugs and appeared to be independent of the degree of renal insufficiency (Tables 2, 3 , 5, and 6).
Dosage adjustment in patients with renal insufficiency. As no major pharmacokinetic difference was observed when cefotiam and cefsulodin were given together, the dosage adjustment suggested for the two cephalosporins given alone can be applied (7; Rouan et al., in press).
These adjustments in percentage of the dose given to a subject with normal renal function are summarized in Table   8 . The doses have been calculated to yield the same maximum concentration as in a subject without renal impairment during chronic treatment (1, 2) . When a reduced dose is to be given, a loading dose equal to 100% of that given to a subject with normal renal function is recommended to rapidly produce steady-state plasma concentrations. In anuric patients, a loading dose is also to be given just after the end of dialysis. The subsequent doses should be reduced as recommended for anuric patients (see Table 8 , CLCR < 20 ml/min). b When the CLCR was <5, 75% of the cefsulodin dose was given.
